…n patients with systemic lupus erythematosus (SLE) treated with belimumab (BEL).Methods Retrospective longitudinal cohort study from the …
Belimumab
This drug is selected. Its supporting articles are shown below.
Articles mentioning Belimumab
69 articles · page 4 of 6…ients receiving intravenous methylprednisolone pulse therapy or belimumab in the non-relapse group was significantly higher. Using LASSO-…
…D study ( NCT05878717) is evaluating the efficacy and safety of belimumab in patients with SSc-ILD; it will be important to assess the re…
…g pooled baseline and week 52 data from two phase III SLE RCTs (Belimumab in Subjects with Systemic Lupus Erythematosus (BLISS)-52, NCT00…
…I was 0 (0-1.25). Standard treatments during pregnancy included prednisone (83%), antimalarials (86%), azathioprine (47%); calcineurin-inh…
…vity, Lupus nephritis. She was treated with Methylprednisolone, Hydroxychloroquine, Azathioprine, one infusion of Belimumab. After 18 month evolut…
…essants: calcineurin inhibitors (3/5), mycophenolate (2/5), and belimumab (1/5). The most frequent extrarenal manifestations were arthrit…
…Objectives Belimumab (BEL), a B-cell modulator mAb that selectively inhibits soluble…
…treatments included glucocorticoids (72.4%), immunosuppressants—methotrexate, azathioprine, or mycophenolate—(46%) and antimalarials (82.7%)…
…ntibodies are associated with response to rituximab followed by belimumab. This study aimed to investigate IgA2+ B cells in SLE using 5’ …
…rienced an improvement 74.6% had managed to completely withdraw prednisone .77.6% were still on BEL treatment.Conclusions In the Spanish c…
…Objectives Belimumab (BEL) is an IgG1 antibody against the soluble form of B-cell ac…